武汉费斯德生物科技有限公司, NewEast Biosciences 中国办事处

邮箱:2716620741@qq.com

咨询:027 – 63497286 

CHRND Rabbit pAb

Anti-CHRND Rabbit Polyclonal Antibody
5/5

¥2,850.00

货号:S215494

规格: 100 微升

库存状态:In Stock

           产品描述          
货号:   S215494
产品全名:   CHRND 兔多抗
基因符号   ACHRD; CMS2A; CMS3A; CMS3B; CMS3C; FCCMS; SCCMS
UNIPROT ID:   Q07001 (Gene Accession – NP_000742 )
背景:   The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene.
抗原:   Synthetic peptide of human CHRND
经过测试的应用:   ELISA, IHC
推荐稀释比:   IHC: 25-50; ELISA: 5000-10000
种属反应性:   Rabbit
克隆性:   Rabbit Polyclonal
亚型:   Immunogen-specific rabbit IgG
纯化:   Antigen affinity purification
种属反应性:   Human
成分:   PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.05% Sodium Azide and 40% glycerol
研究领域:   Neuroscience
储存和运输:   Store at -20°C. Avoid repeated freezing and thawing

Immunohistochemistry analysis of paraffin embedded Human liver cancer tissue using 215494(CHRND Antibody) at a dilution of 1/25(Cytoplasm).

In comparision with the IHC on the left, the same paraffin-embedded Human liver cancer tissue is first treated with the synthetic peptide and then with 215494(Anti-CHRND Antibody) at dilution 1/25.

The image on the left is immunohistochemistry of paraffin-embedded Human tonsil tissue using 215494(Anti-CHRND Antibody) at a dilution of 1/25.

In comparision with the IHC on the left, the same paraffin-embedded Human tonsil tissue is first treated with synthetic peptide and then with D163454(Anti-CHRND Antibody) at dilution 1/25.
           引用文献